Phase II Trial of Weekly Nab (Nanoparticle Albumin Bound)-Paclitaxel (Nab-paclitaxel) (Abraxane®) in Combination With Gemcitabine in Patients With Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 31 May 2011
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 May 2011 Actual end date changed from Dec 2010 to Aug 2010 as reported by ClinicalTrials.gov.
- 25 May 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 25 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.